Mayo Clinic Researchers Identify DNA Gene-Control Changes Linked to Alzheimer’s Disease
Scientists examining brain tissue from hundreds of patients have discovered specific gene-regulating changes strongly linked to the tau protein in Alzheimer’s disease, according to a study published by Mayo Clinic researchers. The findings point to potential alterations in oligodendrocytes, the brain cells responsible for producing myelin, which is the protective layer that allows nerve signals to move efficiently.
Age remains the greatest risk factor for Alzheimer’s disease, but aging alone does not fully explain why certain individuals develop the neurodegenerative condition while others do not. According to a Newswise report and coverage from the Mayo Clinic News Network, genetics, environmental influences, and lifestyle factors all contribute to the disease. More than 7 million Americans live with Alzheimer’s disease, the most common cause of dementia, and that total is projected to increase as the population ages.
Beyond Amyloid and Tau Proteins in Brain Tissue
Traditional research has concentrated heavily on the buildup of amyloid and tau proteins in the brain. While those proteins remain central to pathology, Nilüfer Ertekin-Taner, M.D., Ph.D., a neurologist and neuroscience chair at Mayo Clinic in Florida, noted that researchers now recognize Alzheimer’s as a complex disease involving multiple biological processes beyond protein accumulation.
The recent study investigated epigenetics, which involves how cells turn genes on and off. Cells control active and inactive genes to perform different functions without altering the underlying DNA sequence. By analyzing brain tissue samples from hundreds of individuals with Alzheimer’s disease, the research team mapped patterns in these gene-regulating changes and linked several directly to the tau protein.
Oligodendrocytes and Myelin Damage in Neural Communication
The research highlighted the role of oligodendrocytes, specialized brain cells that support nerve cells by generating myelin. Myelin forms a protective sheath that ensures rapid and efficient signal transmission across neural pathways. When myelin sustains damage, communication between brain cells breaks down.
The findings suggest that Alzheimer’s disease may involve not only damage to nerve cells but also changes in the systems that support how those cells communicate with one another,
Dr. Ertekin-Taner explained, according to the Newswise report. This shift in perspective encourages investigators to look beyond traditional disease models.
Potential for Reversible Gene Control in Future Therapies
The newly identified epigenetic mechanisms will not immediately alter current diagnostic or treatment protocols for patients. Dr. Ertekin-Taner stated that scientists must first replicate the findings, understand how the gene-control alterations affect neural tissue, and establish whether the discoveries can yield safe treatments.
Unlike inherited DNA mutations, certain epigenetic gene-control changes can be reversible. This characteristic serves as a primary driver of interest for investigators exploring future targeted therapies, though extensive additional research remains necessary.
Multiomic Atlas of AD Brain Endophenotypes Resource
To support global research efforts, the Mayo Clinic team built a free, searchable online database titled the Multiomic Atlas of AD Brain Endophenotypes. Scientists worldwide can access the platform to examine specific genes, view interactive tables, and analyze data from the study to accelerate discoveries in neurodegenerative conditions.
Frequently Asked Questions
Does this new study provide a cure or prevention for Alzheimer’s disease?
No single study has found a cure or isolated a single cause for Alzheimer’s disease. The research identifies specific epigenetic and cellular clues that may help guide future treatments and personalized approaches to prevention.
What specific brain cells were highlighted in the study?
The research highlighted oligodendrocytes, which are brain cells that produce myelin to protect nerve fibers and facilitate efficient signal transmission between neurons.
How can other scientists access the data from this research?
The Mayo Clinic research team created a free online database called the Multiomic Atlas of AD Brain Endophenotypes, allowing investigators worldwide to look up specific genes and view interactive data tables and graphs.
Related reading